Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Background: P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) play a critical role in keeping neurotoxic substances from entering the brain. We and others have previously reported an impact of inflammation on the regulation of adult blood–brain barrier (BBB) efflux transporters. However, studies in children have not been done. From the pediatric clinical perspective, it is important to understand how the central nervous system (CNS) and BBB drug efflux transporters differ in childhood from those of adults under normal and inflammatory conditions. Therefore, we examined and compared the regulation of P-gp and BCRP expression and transport activity in young and adult BBB and investigated the molecular mechanisms underlying inflammatory responses. Methods: Rats at postnatal day (P) P21 and P84, corresponding to the juvenile and adult stages of human brain maturation, respectively, were treated with endothelin-1 (ET-1) given by the intracerebroventricular (icv) route. Twenty-four hours later, we measured P-gp and BCRP protein expression in isolated brain capillary by immunoblotting as well as by transport activity in vivo by measuring the unbound drug partitioning coefficient of the brain (K p,uu,brain) of known efflux transporter substrates administered intravenously. Glial activation was measured by immunohistochemistry. The release of cytokines/chemokines (interleukins-1α, 1-β (IL-1β), -6 (IL-6), -10 (IL-10), monocyte chemoattractant protein (MCP-1/CCL2), fractalkine and tissue inhibitor of metalloproteinases-1 (TIMP-1)) were simultaneously measured in brain and serum samples using the Agilent Technology cytokine microarray. Results: We found that juvenile and adult BBBs exhibited similar P-gp and BCRP transport activities in the normal physiological conditions. However, long-term exposure of the juvenile brain to low-dose of ET-1 did not change BBB P-gp transport activity but tended to decrease BCRP transport activity in the juvenile brain, while a significant increase of the activity of both transporters was evidenced at the BBB in the adult brain. Moreover, juvenile and adult brain showed differences in their expression profiles of cytokines and chemokines mediated by ET-1. Conclusions: BBB transporter activity during neuroinflammation differs between the juvenile and adult brains. These findings emphasize the importance of considering differential P-gp and BCRP transport regulation mechanisms between adult and juvenile BBB in the context of neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







![Figure 7 Cytokines and chemokines levels for 24 hours in juveniles (P21) and adult (P84) rat brains after a single intracerebral injection of endothelin-1. All cytokines, IL-1α, IL-1β, IL-6, IL-10, MCP-1/ccl2, fractalkine and TIMP-1 were simultaneously measured in brain and serum samples using the Agilent technology cytokine microarray (Tebu-bio). All brain values were corrected for individual serum measurements as described previously [6]. Comparisons between groups were performed using one-way analysis of variance (ANOVA) with the Student-Bonferroni post test. Data are presented as mean ± S.E.M. Statistical significance was set at P <0.05. Graph plotted as mean ± S.E.M. *P <0.05, **P <0.01, ***P < 0.0001 compared with animal controls. The number of animal tested: n = 3 or 5 rats for each group.](https://figures.cochat.ai/paper-figures/5029eb5d7b754952ae6693ef0efb5f43/susceptibility-of-juvenile-and-adult-bloodbrain-barrier-to-endothelin-1-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 9×
“All cytokines, IL-1 β, IL-6, IL-10, MCP-1/ccl2, fractalkine, TIMP-1, IL-13, cinculin (CINC-1) were simultaneously measured in brain and serum samples using the Agilent technology cytokine microarray (Tebu bio).”
BackgroundInfluentialCyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925 · cited 1×
“Inflammation regulates a number of intracellular signal transduction pathways [59-61] involved in the regulation of transporter activity.”
BackgroundReactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766 · cited 1×
“Indeed, IL6 is a well-known marker of glial activation [56] and the autocrine action of this interleukin on glial cells might account for an increase of ABC transporters at the cell surface.”
BackgroundMicroglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645 · cited 1×
“and once activated they release numerous inflammatory molecules, particularly pro and anti-inflammatory cytokines and chemokines [47] (Proinflammatory molecules such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) [48-50], chemokines (IL-8, MIP-1α, MIP-1β, MCP-1) [51,52], proteases [53…”
BackgroundBasic Neurochemistry: Molecular, Cellular, and Medical Aspects
Siegel, G. J., & Agranoff, B. W. (1989) · Cited by 1,359
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 3×
“Concomitant with GFAP overexpression, astrocytes release many proinflammatory mediators and upregulate the expression of several inflammatory molecules, contributing to the amplification of inflammation [34].”
BackgroundResultBasic Neurochemistry???Molecular, Cellular, and Medical Aspects
Long, D. M. (2006) · Neurosurgery Quarterly · doi:10.1097/01.wnq.0000203279.82150.41 · Cited by 1,284
Aloisi, F. (2001) · Glia · doi:10.1002/glia.1106 · Cited by 1,280 · cited 9×
“All cytokines, IL-1 β, IL-6, IL-10, MCP-1/ccl2, fractalkine, TIMP-1, IL-13, cinculin (CINC-1) were simultaneously measured in brain and serum samples using the Agilent technology cytokine microarray (Tebu bio).”
BackgroundInfluentialMicroglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919 · cited 1×
“Rapidly, in response to infection or injury, microglia, major inflammatory cells of the monocyte/microphage lineage that reside in the brain, are activated [46].”
BackgroundDrug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900 · cited 1×
“Adenosine triphosphate-binding cassette (ABC) transporters play a critical role in keeping neurotoxic substances from entering the brain and in transporting toxic metabolites out of the brain [1,2].”
Background
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“28,29 But it also limits the drugs that enter into the CNS for treating brain diseases such as neurodegenerative diseases and brain cancer.”
BackgroundCrossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
“The BBB protects the brain from foreign substances in the blood that may damage the brain and keep a constant brain environment [3].”
BackgroundBlood-Brain Barrier Overview: Structural and Functional Correlation
Alahmari, A. (2021) · Neural Plasticity · doi:10.1155/2021/6564585 · Cited by 299
Efflux transporters in blood-brain interfaces of the developing brain
Strazielle, N., & Ghersi-Egea, J.-F. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00021 · Cited by 157
Schulz, J., Hartz, A. M. S., & Bauer, B. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000025 · Cited by 122
“At later stages of development, TNFa signaling decreases Abcg2 activity at the rat bloodbrain barrier (Harati et al., 2012).”
Background
Metadata
- Authors
- Harati, R., Villégier, A.-S., Banks, W. A., & Mabondzo, A.
- Affiliations
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Institut national de l'environnement industriel et des risques (FR)
- University of Washington (US)
- Venue
- Journal of Neuroinflammation
- Published
- 2012-12
- Volume
- 9
- Issue
- 1
- Pages
- 273-273
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC3547749
- OpenAlex
- W2124502931
- Cited by
- 45
- References
- 64
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- creativecommons.org/licenses/by/2.0 (vor, 18 d)
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Styrelsen för Internationellt Utvecklingssamarbete
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- blood-brain barrier, endothelin-1, P-glycoprotein, ABCG2, efflux pumps, neuroinflammation, brain maturation, juvenile brain, adult brain, cytokines and chemokines, glial activation, brain capillary endothelium, drug efflux, neuroprotection, postnatal development, rats, interleukin-1
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Age Factors, Analysis of Variance, Animals, Animals, Newborn, Biological Transport, Biological Transport, Active, Blood-Brain Barrier, Brain, Drug Administration Routes, Glial Fibrillary Acidic Protein, Male, Methylene Blue, RNA, Messenger, Cytokines, Rats, Wistar, ATP Binding Cassette Transporter, Subfamily B, Gene Expression Regulation, Developmental, ATP-Binding Cassette Transporters, Endothelin-1, Rats, Microvessels, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. https://app.cochat.ai/papers/10.1186/1742-2094-9-273
- The paper
- Harati, R., Villégier, A.-S., Banks, W. A., & Mabondzo, A. (2012). Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-9-273
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.